CG
PBH icon

Colony Group’s Prestige Consumer Healthcare PBH Stock Holding History

Colony Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,562
Closed -$1.59M – 290
2016
Q4 		$1.59M Sell
30,562
-1,681
-5% -$81.1K 0.17% 143
2016
Q3 		$1.56M Sell
32,243
-43,510
-57% -$2.2M 0.17% 127
2016
Q2 		$4.2M Buy
75,753
+300
+0.4% +$16.5K 0.46% 55
2016
Q1 		$4.03M Buy
75,453
+858
+1% +$42.3K 0.47% 54
2015
Q4 		$3.84M Buy
74,595
+2,185
+3% +$109K 0.35% 69
2015
Q3 		$3.27M Buy
+72,410
New +$3.42M 0.38% 64

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Colony Group's PBH Position: Q1 2017 in Review

Colony Group sold out of Prestige Consumer Healthcare (PBH) in Q1 2017, closing a stake of 30,562 shares — an estimated $1.59M sold.

Colony Group first reported a position in PBH in Q3 2015 and held it in 6 quarters. The position peaked at $4.2M in Q2 2016. 241 funds tracked by Wall St. Rank hold PBH as of Q1 2017.

  • Colony Group reported no remaining Prestige Consumer Healthcare position as of Q1 2017 after selling out during the quarter.
  • Colony Group sold 30,562 Prestige Consumer Healthcare shares in Q1 2017, an estimated $1.59M.
  • Colony Group first reported a position in Prestige Consumer Healthcare in Q3 2015 and held it in 6 quarters.
  • Colony Group's Prestige Consumer Healthcare position peaked at $4.2M in Q2 2016.
  • 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2017.

Based on Colony Group's 13F filing for Q1 2017, filed 16 May 2017.